MMS vs TLRY · P/E 8.1, rev $5.43B vs rev $915.5M
Maximus Inc (MMS) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Maximus Inc (MMS) is a specialty business services company listed on US.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported MMS revenue for 2025-09-30 was $5.43B. Net income was $319.0M. MMS currently screens at market cap $2.82B and trailing P/E 8.1.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
MMS currently screens at market cap $2.82B and trailing P/E 8.1. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the MMS and TLRY stock pages for the full models.
Not investment advice.